Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Yabang Shengyuan Pharmaceutical is a core subsidiary of the Yabang Investment Holding Group, specializing in the manufacturing and distribution of chemical pharmaceuticals and active pharmaceutical ingredients (APIs). Located in the Wujin District of Changzhou, the company operates high-standard production lines for various dosage forms, including tablets, capsules, and granules. Its therapeutic focus includes cardiovascular health, anti-infectives, and metabolic disorders, with a strong market presence in generic medications. The company leverages the integrated industrial chain of the Yabang Group to maintain competitive advantages in raw material supply and quality control. Yabang Shengyuan is committed to meeting international quality standards and plays a significant role in the Chinese domestic pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yabang 生缘药业.